advanced search

Aptar Pharma

Aptar Pharma provides drug delivery systems, components and services globally. Products include: nasal spray pumps, MDI valves, dose indicators & counters, DPIs, electronic / connected devices, eye-droppers, vial stoppers, prefilled syringe (PFS) plungers and other components, and more.


Visit Website



Associated Companies

  Aptar Digital Health     Gateway Analytical     Nanopharm     Next Breath     Noble  

Headquarters
Aptar Louveciennes
38 Rue de la Princesse
78430 Louveciennes
France

Phone / Contact

T: + 33 1 39 1720 20

Connect

Aptar Pharma is one of the drug delivery device industry’s major companies, providing drug delivery systems, components and services to pharmaceutical, biotech and consumer healthcare customers worldwide, across the nasal, pulmonary, ophthalmic, dermal and injectable routes of administration.

Products include: nasal spray pumps, MDI valves, dose indicators and counters, DPIs, electronic devices, connected devices, eye-droppers, vial stoppers, prefilled syringe (PFS) plungers and other components, and more.

Overall, six billion components and systems are produced annually across 12 manufacturing sites and are accessed by 1.6 billion patients, and over US$50 billion worth of pharmaceutical products use Aptar Pharma’s systems.

The company’s services include: customised development, laboratory services, regulatory and technical support, and elastomer development.

In November 2019, Aptar Pharma acquired Noble.

Aptar Pharma is part of AptarGroup, Inc (NYSE:ATR).

Articles by Aptar Pharma

INTERVIEW
Julien Storz
INTERVIEW: PUREHALE® AND THE FUTURE OF FINE MIST DISPENSERS FOR UPPER AIRWAY TREATMENTS
Julien Storz and Giulia Mueller discuss the latest trends and treatment options available for upper airway conditions, along with the many benefits offered by Aptar Pharma’s advanced PureHale® systems to manufacturers.
INJECTION
Antonio Scatena
BEYOND PROBABILITY: CHOOSING DETERMINISTIC METHODS FOR RELIABLE CONTAINER CLOSURE INTEGRITY TESTING
Antonio Scatena answers some of the most common questions regarding the container closure integrity testing methods used to detect leaks and defects – and discusses how the industry can meet the updated expectations set by regulatory bodies.
INDUSTRIALISATION
Sebastien Cordier
MACHINABILITY OF ETFE-FILM-COATED PREFILLED SYRINGE PLUNGER WITH VENT-TUBE INSERTION
Sebastien Cordier, Benjamin Brocco, Audrey Chardonnet and Edgar Bauer discuss the results of tests on the performance of PremiumCoat® syringe plungers on high-speed fill-finish operations with vented insertion.
INJECTION
Dr Laure-Helene Guillemot
VIAL STOPPER COMPATIBILITY: CRITERIA AND TESTING METHODS FOR PHARMACEUTICAL PACKAGING
Laure-Hélène Guillemot, Benjamin Brocco, Edouard Pagnoud and Pascal Sircoulomb, discuss some of the key parameters to consider when choosing a vial stopper and present evaluation methods that were developed to test and demonstrate the compatibility of various stoppers with commonly used vial designs.
INTERVIEW
Dr Julie Suman
Interview: EXPLORING NASAL CASTS IN NASAL DRUG DEVELOPMENT
Julie Suman discusses nasal casts, their development, applications and significance for nasal drug product development. 
RESPIRATORY
Gemma Budd
ADVANCING OINDP CLINICAL TRIALS WITH SPEED AND EFFICIENCY: STRATEGIES FOR SUCCESS
Gemma Budd and Julie Suman, consider the key issues that preclinical and clinical trials for orally inhaled and nasal drug products must address within the context of the information that regulators are looking for, providing insight, strategies and advice for both novel and generic products in this sector.
INJECTION
Antonio Scatena
EXPLORING EXTRACTABLE AND LEACHABLE TESTING STRATEGIES FOR PARENTERALS
Antonio Scatena, Scott Toth and Kyle Chenevert  discuss the regulatory landscape regarding extractables and leachables for parenteral drugs and provide guidance on implementing a successful testing approach. Techniques and results interpretation are discussed, emphasising practical advice for developers working towards regulatory submission.
INTERVIEW
Claire Raynal-Olive
Interview with Claire Raynal-Olive & Pierre-Yves Favennec
Claire Raynal-Olive and Pierre-Yves Favennec discuss the strategy and objectives of Aptar Pharma’s expansion programme of its global rubber component manufacturing, implementing advanced technology, increased capacity and local-for-local manufacturing capability.
PREFILLED SYRINGES
Edouard Pagnoud
PRIMARY PACKAGING CONSIDERATIONS FOR SUPPORTING COMPLIANCE TO ANNEX 1 REVISION
Edouard Pagnoud, Estelle Verger and Benjamin Brocco look at the new requirements associated with EMA GMP Annex 1 revision regarding injectable primary packaging for ensuring sterility and safety, and consider how Aptar's PremiumFill® can reduce the risk of contamination and defects.
CONNECTIVITY
Dr Corinne Fechant
TAKING A PATIENT-CENTRIC APPROACH TO CANCER CARE THROUGH IMMUNOTHERAPY
Corinne Fechant and Laura Hilliquin highlight the role digital health solutions can play in supporting patient self-administration for the increasing number of immunotherapies for cancer treatment.
INJECTION
Sebastien Cordier
COLD STORAGE AND CONTAINER CLOSURE INTEGRITY – DEMONSTRATED PERFORMANCE OF ETFE-COATED COMPONENTS
Sebastien Cordier; Benjamin Brocco; Estelle Verger and Arnaud Clausse discuss the results of a series of tests to demonstrate that PremiumCoat® can maintain closure integrity down to -80°C.
INTERVIEW
Julien Storz
WHY SUSTAINABLE PACKAGING MATTERS IN PHARMA’S CIRCULAR APPROACH – APTAR PHARMA’S FUTURITY PLATFORM LEADS THE WAY
Julien Storz discusses the importance of sustainable packaging in the pharma industry and introduces the company’s Futurity platform and its role in product circularity.
SUSTAINABILITY
Chris Baron
NAVIGATING pMDI REFORMULATION 2.0
Chris Baron and William Ganley examine possible responses to the environmental impact of pressurised metered dose inhalers use and consider alternative inhaler types, with a focus on the strategies and support that can accelerate the development of the next generation of pMDIs.
NASAL
Dr Julie Suman
THE POTENTIAL AND THE CHALLENGES OF NASAL VACCINATION
Julie Suman and Nektaria Karavas discuss the challenges and opportunities of intranasal vaccination – showcasing current understanding for both liquid and powder products. Experimental studies highlight critical issues, the performance of commercially available devices and developments in formulation practice.
INTERVIEW
Dr Stefan Hellbardt
DE-RISKING COMBINATION PRODUCT REGISTRATION FOR SEMI-SOLIDS WITH APTAR PHARMA’S AIRLESS+ SYSTEM – AN INTERVIEW WITH STEFAN HELLBARDT
Stefan Hellbardt discusses the increasing demand for airless systems in the dermal drug delivery market, the advantages of these systems and Aptar Pharma’s own offering in this space, including its Airless+ packaging system and Extended Support services.
INTERVIEW
Guy Furness
Interview: Gabriel Zenker, Aptar Pharma
Gabriel Zenker talks with ONdrugDelivery about Aptar Pharma’s ambitions for the parenterals sector. Mr Zenker explains how Aptar, already a major player in the pulmonary, nasal, ophthalmic and dermal markets, is undertaking a major expansion of its facilities, boosting the company’s capacity, capabilities and technologies, to provide its extensive service and product offering to the exciting injectables space.
CONNECTIVITY
Benjamin D’hont
BUILDING DIGITAL SOLUTIONS TO MEET THE UNIQUE THERAPEUTIC NEEDS OF PATIENTS
Benjamin D’hont and Joe Reynolds discuss how the key to maturing the digital health market and increasing user retention of digital health apps is integrating agile app development from the beginning of a therapeutic’s development cycle.
NASAL
Reenal Gandhi
STEPS TO SUCCESS IN NOSE-TO-BRAIN DRUG DELIVERY
Reenal Gandhi and Gemma Budd consider the multiple hurdles associated with developing nasal drug delivery solutions, current understanding of the associated biology and the advantages of alternative device designs and state-of-the-art formulation practice.
SUSTAINABILITY
Matthias Birkhoff
SUSTAINABILITY MEASURES ARE THE KEY TO MEETING ESG COMMITMENTS
Matthias Birkhoff and Christophe Marie discuss the advances Aptar Pharma has made in delivering on its sustainability objectives.
CONNECTIVITY
Romain Marmot
HOW DIGITAL THERAPEUTICS ADD VALUE TO TREATMENTS FOR COMPLEX CONDITIONS
Romain Marmot discusses how external partners with a track record of developing digital therapeutics for numerous chronic conditions and therapies can help life science organisations implement digital solutions across their pipeline, adding value to each therapy while improving medication adherence and clinical outcomes.
PREFILLED SYRINGES
Sebastien Cordier
PREMIUMCOAT® SOLUTIONS: HELPING CONTROL THE LEVEL OF SILICONE TO PROTECT SENSITIVE THERAPEUTICS
Sébastien Cordier, Vincent Holterboch and Estelle Verger discuss how coated elastomer components, such as Aptar Pharma’s PremiumCoat®, can help drug developers optimise the balance between component processability and minimising silicone migration into a drug product.
SUSTAINABILITY
Chris Baron
INVESTIGATING THE PROPELLANT PATHWAYS LEADING TO A SUSTAINABLE FUTURE FOR MDIS
Chris Baron and Jag Shur discuss the various dynamics involved in realising the full potential of MDIs to deliver both improved environmental performance and even better patient outcomes.
EXPERT VIEW
Dr Justin Lacombe
USING QUALITY BY DESIGN TO OPTIMISE THE COMBINATION PRODUCT JOURNEY
Justin Lacombe and Julie D Suman explain how applying quality by design principles to combination products improves development efficiency, aligns with design controls, and maximises product safety and efficacy.
OCULAR
Alexandra Ritter
AN EYE ON THE FUTURE OF PRESERVATIVE-FREE DROPS
Alexandra Ritter and Matthias Birkhoff discuss the importance of the regulatory support the company offers to its customers for preservative-free ophthalmic platforms in the face of increasingly stringent regulatory requirements from both the EU EMA and US FDA, and describe new opportunities and growing demand for a wider range of multidose preservative-free ophthalmic drug-device combinations, including for indications such as dry-eye and glaucoma.
Top